ELEVEGIO
Live / Applied — Withdrawn from publication (as of 06 Nov 2026)
What this means for you
Not registered yet, but its 02 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99524692
- Mark type
- Word mark
- Filed
- 02 Dec 2025
- Published for opposition
- 24 Nov 2026
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Medical preparations, namely, medicine for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; anti-cancer preparations of chemical origin; anti-cancer preparations; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer
Owner
- Elevar Therapeutics, Inc., Fort Lee, NJ, US
Prosecution history
- 06 Nov 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 30 Oct 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 17 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Oct 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Oct 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Jul 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Jul 2026 — NON-FINAL ACTION E-MAILED
- 14 Jul 2026 — NON-FINAL ACTION WRITTEN
- 11 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION WRITTEN